Design Highlights
- Insurance brokers may engage in collusive practices like “last looks,” limiting competition and violating antitrust laws.
- The tightening of D&O insurance coverage creates significant risks for healthcare organizations, especially concerning antitrust and regulatory issues.
- The McCarran-Ferguson Act historically exempts insurers from antitrust laws, but its scope is narrowing, affecting unethical practices.
- Economic pressures on smaller insurers risk insolvency, reducing consumer choices and potentially raising premiums across the industry.
- International regulatory changes, like those in the EU, could influence domestic insurance practices and increase scrutiny on collusion.
What’s going on with insurance companies these days? If you’re thinking it’s just business as usual, think again. It’s a wild ride out there, especially for healthcare organizations. Directors and Officers (D&O) insurance? Yeah, that’s facing some serious restrictions lately. For over a decade, coverage for antitrust and regulatory issues was pretty straightforward. But since 2018-2019, insurers decided to tighten the reins. Profits are down, and guess who’s feeling the heat? The healthcare systems, particularly the big players raking in over a billion bucks annually.
Imagine this: retentions on antitrust claims have skyrocketed from low six figures to seven figures. That’s right, folks. If you thought you could just waltz in and get covered, think again. And coinsurance? It’s gone from a comfy 20% to a staggering 50%. Want regulatory coverage? Good luck. Now it’s limited to defense costs only. So, you’re basically on your own when it comes to the big stuff.
Retentions for antitrust claims have skyrocketed to seven figures, while coinsurance has doubled to 50%. Regulatory coverage? You’re mostly on your own now.
But wait, there’s more! The insurance brokerage world isn’t all sunshine and rainbows either. Allegations are swirling about brokers and insurers colluding to divvy up clients, stifling competition like it’s a bad reality show. They’ve got tricks, like “last looks” and “first looks” on bids. That’s right—collusion wrapped in a shiny package, violating the Sherman Act. Who knew insurance could be so scandalous?
And what about the McCarran-Ferguson Act? It’s been around since 1945, giving state-regulated insurance a nice little antitrust exemption. But that doesn’t mean everything is peachy. The Supreme Court has been narrowing its scope, keeping it from becoming a blanket shield for unethical practices. The increasing trend towards blanket exclusions is causing even more concern for those seeking adequate coverage. Additionally, the McCarran-Ferguson Act has historically aimed to maintain state regulation while still offering federal remedies.
Smaller insurers, the backbone of competition, are in a tough spot. A third of U.S. property and casualty insurers are small, and without pooled data, they’re flirting with insolvency. It’s a dangerous game. If the exemption changes, expect premiums to rise and choices to dwindle. In fact, 75% of small businesses are already considered inadequately insured, leaving them dangerously exposed to financial risks when unexpected events occur.
Across the pond, international regulations are shaking things up. In the Netherlands, changes are afoot, allowing brokers to get direct remuneration. The EU is also nudging towards a more nuanced approach to antitrust in insurance.
